4D Molecular Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $339.9M
Liabilities Breakdown FY2023
Total Liabilities: $32.1M
Asset Breakdown
Total Assets: $339.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $249.1M | 73.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $20.1M | 5.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $70.7M | 20.8% |
Liabilities Breakdown
Total Liabilities: $32.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.5M | 11.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $28.5M | 89.0% |